Wim Lemahieu

1.5k total citations
17 papers, 654 citations indexed

About

Wim Lemahieu is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Nephrology. According to data from OpenAlex, Wim Lemahieu has authored 17 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pediatrics, Perinatology and Child Health and 6 papers in Nephrology. Recurrent topics in Wim Lemahieu's work include Pharmacological Effects and Toxicity Studies (8 papers), Drug Transport and Resistance Mechanisms (7 papers) and Renal Transplantation Outcomes and Treatments (6 papers). Wim Lemahieu is often cited by papers focused on Pharmacological Effects and Toxicity Studies (8 papers), Drug Transport and Resistance Mechanisms (7 papers) and Renal Transplantation Outcomes and Treatments (6 papers). Wim Lemahieu collaborates with scholars based in Belgium and Norway. Wim Lemahieu's co-authors include Bart Maes, Kristin Verbeke, Yves Vanrenterghem, Karel Geboes, Yves Vanrenterghem, Hallvard Holdaas, Monica Hermann, Paul Rutgeerts, Anders Åsberg and Sara Ombelet and has published in prestigious journals such as Kidney International, American Journal of Kidney Diseases and American Journal of Transplantation.

In The Last Decade

Wim Lemahieu

16 papers receiving 628 citations

Peers

Countries citing papers authored by Wim Lemahieu

Since Specialization

Citations

This map shows the geographic impact of Wim Lemahieu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wim Lemahieu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wim Lemahieu more than expected).

Fields of papers citing papers by Wim Lemahieu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wim Lemahieu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wim Lemahieu. The network helps show where Wim Lemahieu may publish in the future.

Co-authorship network of co-authors of Wim Lemahieu

This figure shows the co-authorship network connecting the top 25 collaborators of Wim Lemahieu. A scholar is included among the top collaborators of Wim Lemahieu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wim Lemahieu. Wim Lemahieu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Treatment of Osteoporosis in Patients with Chronic Kidney Disease 2025 ·Current Osteoporosis Reports ·Michaël R. Laurent, Jolan Dupont, Wim Lemahieu, Sofie Jamar, (unknown), Marian Dejaeger, Evelien Gielen, Pieter Evenepoel	0
2	Atypical Hemolytic Uremic Syndrome Occurring After Receipt of mRNA-1273 COVID-19 Vaccine Booster: A Case Report 2022 ·American Journal of Kidney Diseases ·Kathleen Claes, (unknown), Wim Lemahieu, Alexander Wilmer, (unknown), Priyanka Koshy, Sara Ombelet	13
3	Frailty and Mortality in Hospitalized Older Adults With COVID-19: Retrospective Observational Study 2020 ·Journal of the American Medical Directors Association ·(unknown), (unknown), (unknown), (unknown), Eric Frans, Sara Ombelet, Wim Lemahieu, Rolf Symons, Erwin Ho, Johan Frans, Annick Smismans, Michaël R. Laurent	117
4	Reversal of Dialysis-Dependent Anti–Glomerular Basement Membrane Disease Using Plasma Exchange, Glucocorticosteroids, and Rituximab 2018 ·Kidney International Reports ·Wim Lemahieu, Sara Ombelet, Evelyne Lerut, Sofie Jamar, Ben Sprangers	5
5	External Validation of a risk stratification model to assist shared decision making for patients starting renal replacement therapy 2016 ·BMC Nephrology ·Patrick Peeters, Wim Van Biesen, Nic Veys, Wim Lemahieu, Bart De Moor, Johan De Meester	10
6	High anion gap metabolic acidosis: use the proper acronym, discard the red herrings and thou shall find the culprit 2014 ·Clinical Kidney Journal ·(unknown), Wim Lemahieu, Eric Frans	6
7	In Vivo Assessment of Cytochrome P450 3A4 and P-Glycoprotein Activity:Impact on Clinical Practice 2007 ·Current Enzyme Inhibition ·Wim Lemahieu, Bart Maes	3
8	Comparison of peritoneal dialysis and haemodialysis after renal transplant failure 2006 ·Nephrology Dialysis Transplantation ·Hylke de Jonge, Bert Bammens, Wim Lemahieu, Bart Maes, Yves Vanrenterghem	46
9	Impact of gastric acid suppressants on cytochrome P450 3A4 and P-glycoprotein: Consequences for FK506 assimilation 2005 ·Kidney International ·Wim Lemahieu, Bart Maes, Kristin Verbeke, Yves Vanrenterghem	18
10	Cytochrome P450 3A4 and P-glycoprotein Activity and Assimilation of Tacrolimus in Transplant Patients with Persistent Diarrhea 2005 ·American Journal of Transplantation ·Wim Lemahieu, Bart Maes, Kristin Verbeke, Paul Rutgeerts, Karel Geboes, Yves Vanrenterghem	94
11	Combined Therapy with Atorvastatin and Calcineurin Inhibitors: No Interactions with Tacrolimus 2005 ·American Journal of Transplantation ·Wim Lemahieu, Monica Hermann, Anders Åsberg, Kristin Verbeke, Hallvard Holdaas, Yves Vanrenterghem, Bart Maes	113
12	Different Evolution of Trough and Dose Levels During the First Year After Transplantation for Tacrolimus Versus Cyclosporine 2005 ·Transplantation Proceedings ·Wim Lemahieu, Bart Maes, Yves Vanrenterghem	11
13	CYP3A4 and P-Glycoprotein Activity in Healthy Controls and Transplant Patients on Cyclosporin vs. Tacrolimus vs. Sirolimus 2004 ·American Journal of Transplantation ·Wim Lemahieu, Bart Maes, Kristin Verbeke, Yves Vanrenterghem	69
14	Alterations of CYP3A4 and P-glycoprotein activity in vivo with time in renal graft recipients 2004 ·Kidney International ·Wim Lemahieu, Bart Maes, Kristin Verbeke, Yves Vanrenterghem	20
15	Crohn's‐like changes in the colon due to mycophenolate? 2004 ·Colorectal Disease ·Ignace Dalle, Bart Maes, Karen Geboes, Wim Lemahieu, Karel Geboes	52
16	Measurement of hepatic and intestinal CYP3A4 and PGP activity by combined po + iv [¹⁴C]erythromycin breath and urine test 2003 ·American Journal of Physiology-Gastrointestinal and Liver Physiology ·Wim Lemahieu, Bart Maes, Yvo Ghoos, P. Rutgeerts, Kristin Verbeke, Yves Vanrenterghem	24
17	Differential Effect of Diarrhea on FK506 Versus Cyclosporine A Trough Levels and Resultant Prevention of Allograft Rejection in Renal Transplant Recipients 2002 ·American Journal of Transplantation ·Bart Maes, Wim Lemahieu, Dirk Kuypers, Pieter Evenepoel, Willy Coosemans, Jacques Pirenne, Yves Vanrenterghem	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact